PHARMACYTE BIOTECH, INC. (PMCB) Debt Components
- 2021-04-28: Short-term DebtUSD (m); Notes Payable, CurrentUSD (m); Notes PayableUSD (m); Long-term DebtUSD (m).
- 2020-07-31: Short-term DebtUSD (m); Notes Payable, CurrentUSD (m); Notes PayableUSD (m); Long-term DebtUSD (m).
- 2020-04-30: Short-term DebtUSD (m); Notes Payable, CurrentUSD (m); Notes PayableUSD (m); Long-term DebtUSD (m).
- 2020-03-27: Short-term DebtUSD (m); Notes Payable, CurrentUSD (m); Notes PayableUSD (m); Long-term DebtUSD (m).
PHARMACYTE BIOTECH, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Short-term Debt USD | Notes Payable, Current USD | Notes Payable USD | Long-term Debt USD | Short-term Debt, Percentage Bearing Fixed Interest Rate pure | Debt Instrument, Face Amount USD | Debt Instrument, Interest Rate, Stated Percentage pure | Debt Instrument, Interest Rate, Effective Percentage pure | Debt Instrument, Interest Rate During Period pure | Debt Instrument, Annual Principal Payment USD | Debt Instrument, Decrease, Forgiveness USD | Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate pure | Notes Payable, Related Parties, Noncurrent USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-04-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · $75.20K | (m) | (m) |
| 2020-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.23K | (m) | (m) | (m) |
| 2020-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.23K | (m) | (m) | (m) |
| 2020-03-27 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · 1.00% | (m) | (m) | (m) | (m) |
| 2020-03-27 | (m) | (m) | (m) | (m) | (m) | $75.20K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.00% | (m) | (m) | (m) | (m) | (m) |
| 2014-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.00% | (m) | (m) | (m) | (m) | $0.00 |
| 2014-01-31 | (m) | (m) | $20.00K | (m) | (m) | (m) | 8.00% | 8.00% | (m) | (m) | (m) | (m) | (m) |
| 2013-10-31 | (m) | (m) | $20.00K | (m) | (m) | (m) | 8.00% | 8.00% | (m) | (m) | (m) | (m) | (m) |
| 2013-07-31 | (m) | (m) | $20.00K | (m) | (m) | (m) | 8.00% | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
| 2013-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.00% | (m) |
| 2013-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.00% | (m) |
| 2012-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.00% | (m) |
| 2012-07-31 | (m) | $310.00K | (m) | (m) | 10.00% | (m) | (m) | (m) | (m) | (m) | (m) | 8.00% | (m) |
| 2012-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $173.96K | (m) | (m) |
| 2012-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $173.96K | (m) | (m) |
| 2012-01-31 | $2.21M | (m) | (m) | $247.93K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-10-31 | $2.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-07-31 | $2.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-04-30 | $2.37M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $0.00 | (m) | (m) |
| 2011-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $0.00 | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |